Holen Sie sich die Stockscreener-App
4.18
6.28%
-0.28
Handel nachbörslich:
4.44
0.26
+6.22%
Schlusskurs vom Vortag:
$4.46
Offen:
$4.41
24-Stunden-Volumen:
920.16K
Relative Volume:
1.08
Marktkapitalisierung:
$470.25M
Einnahmen:
$69.56M
Nettoeinkommen (Verlust:
$-240.05M
KGV:
-1.4169
EPS:
-2.95
Netto-Cashflow:
$-121.90M
1W Leistung:
-2.56%
1M Leistung:
+2.45%
6M Leistung:
+190.28%
1J Leistung:
+41.69%
1-Tages-Spanne:
$4.07
$4.43
1-Wochen-Bereich:
$4.07
$4.80
52-Wochen-Spanne:
$1.05
$4.80
Adc Therapeutics Sa Stock (ADCT) Company Profile
Firmenname
Adc Therapeutics Sa
Sektor
Branche
Telefon
41 21 653 02 00
Adresse
BIOPOLE, EPALINGES
Vergleichen Sie ADCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
4.18 | 501.75M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-28 | Eingeleitet | Guggenheim | Buy |
| 2023-08-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-04-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-12-06 | Eingeleitet | CapitalOne | Overweight |
| 2022-11-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | Eingeleitet | Wolfe Research | Outperform |
| 2021-08-17 | Fortgesetzt | Jefferies | Buy |
| 2021-08-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Eingeleitet | Stifel | Hold |
| 2020-10-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-06-09 | Eingeleitet | BofA/Merrill | Buy |
| 2020-06-09 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Adc Therapeutics Sa Aktie (ADCT) Neueste Nachrichten
Using AI based signals to follow ADC Therapeutics SA2025 Key Highlights & Low Risk Investment Opportunities - newser.com
Is ADC Therapeutics SA stock attractive for long term wealth buildingEarnings Performance Report & AI Driven Stock Movement Reports - newser.com
What earnings revisions data tells us about ADC Therapeutics SAVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
ADC Therapeutics (NYSE: ADCT) to host results call Nov. 10 with live webcast - Stock Titan
What insider trading reveals about ADC Therapeutics SA stockJuly 2025 Opening Moves & AI Optimized Trade Strategies - newser.com
Will ADC Therapeutics SA Common Shares stock boost dividends furtherJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - newser.com
Is ADC Therapeutics SA Common Shares stock trading at attractive multiples2025 Market Overview & Fast Exit/Entry Strategy Plans - newser.com
Is ADC Therapeutics SA stock dividend yield sustainableJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
Momentum divergence signals in ADC Therapeutics SA chartStop Loss & Real-Time Volume Surge Alerts - newser.com
Is it time to cut losses on ADC Therapeutics SAJuly 2025 Sentiment & Stock Portfolio Risk Management - newser.com
Will ADC Therapeutics SA Common Shares stock beat Nasdaq index returns2025 Major Catalysts & Real-Time Stock Entry Alerts - newser.com
How institutional ownership impacts ADC Therapeutics SA stock2025 Short Interest & Long-Term Safe Investment Plans - newser.com
ADC Therapeutics SA Hits New 52-Week High of $4.80 - Markets Mojo
Why retail traders accumulate ADC Therapeutics SA Common Shares stockWeekly Stock Recap & Weekly High Return Forecasts - newser.com
Is ADC Therapeutics SA stock a top pick in earnings seasonSwing Trade & Reliable Trade Execution Plans - newser.com
ADC Therapeutics SA (ADCT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What indicators show strength in ADC Therapeutics SAQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com
Why analysts upgrade ADC Therapeutics SA stock2025 Year in Review & Proven Capital Preservation Tips - newser.com
ADC Therapeutics SA stock outlook for YEARJuly 2025 Rallies & Low Drawdown Investment Strategies - newser.com
Published on: 2025-11-01 01:08:52 - newser.com
ADC Therapeutics (NYSE:ADCT) Reaches New 1-Year HighTime to Buy? - MarketBeat
ADC Therapeutics SA (NYSE:ADCT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How to track smart money flows in ADC Therapeutics SA2025 Investor Takeaways & Target Return Focused Picks - newser.com
ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is ADC Therapeutics SA stock bottoming outJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Is ADC Therapeutics SA showing signs of accumulationPortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
Is ADC Therapeutics SA stock cheap compared to fundamentalsWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Visual analytics tools that track ADC Therapeutics SA performance2025 Short Interest & Community Trade Idea Sharing - newser.com
Is ADC Therapeutics SA stock a buy on dips2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Will ADC Therapeutics SA Common Shares stock draw ESG focused funds2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Finanzdaten der Adc Therapeutics Sa-Aktie (ADCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):